Mode
Text Size
Log in / Sign up

PRISM implementation support increased depression care pathway adoption in obstetric practices compared to standard carePregnant Women Are Missing Depression Care — This Program Changes That

AI-generated summary of the cited source, checked by automated accuracy review. How we work

Key Takeaway
Consider that practice-level implementation support may facilitate adoption of depression care pathways in obstetric settings.

This cluster randomized controlled trial involved 294 perinatal individuals with elevated depression symptoms enrolled across ten obstetric practices. Participants were assigned to receive either PRISM, consisting of MCPAP for Moms plus practice-level implementation support, or standard MCPAP for Moms alone. The primary objective was to assess the implementation of a depression care pathway, while secondary outcomes included screening for bipolar disorder, treatment engagement, follow-up monitoring, transition of care plans, identification of perinatal depression, and practice leadership capacity.

Results indicated that the PRISM intervention was associated with a substantially higher likelihood of screening for bipolar disorder (OR = 385.0; p = .001) and identifying individuals as having perinatal depression (OR = 2.3; p = .001) compared to the comparator. Treatment engagement was more likely in the intervention group (OR = 2.8; p = .011), as was follow-up monitoring (OR = 4.0; p = .003) and the creation of a transition of care plan (OR = 2.7; p = .016). Additionally, practice leadership surveys reported a greater increase in capacity to address perinatal depression (3.7 points; p = .005) among practices utilizing the implementation support.

No adverse events, serious adverse events, discontinuations, or tolerability issues were reported. The study design as a cluster randomized controlled trial supports causal inference regarding implementation metrics. However, the study did not report clinical outcomes such as symptom reduction or remission rates. The absence of reported safety data limits the ability to assess the tolerability of the intervention components in this specific context.

Key limitations include the lack of reported adverse events and the focus on implementation metrics rather than direct patient clinical outcomes. Practice-level assistance appears necessary to successfully implement new initiatives aligned with the depression care pathway. Clinicians should consider the potential for practice support to enhance care delivery structures, while awaiting data on patient-centered clinical benefits.

Perinatal Depression Is Common and Commonly Missed

Depression during and after pregnancy — called perinatal depression — affects roughly one in five women. It can appear during pregnancy or in the months after birth and is one of the most common complications of childbirth.

Despite its prevalence, perinatal depression is widely undertreated. Screening happens inconsistently, follow-up care is patchy, and many women fall through the cracks between their OB's office and mental health services. The consequences can be serious — for the mother and for the baby.

Training Alone Has Not Been Enough

Many states have launched programs to train OB providers on perinatal depression — how to screen for it, how to talk about it, how to refer women to help. Massachusetts has run one such program, called MCPAP for Moms, for several years.

But here's the twist: training and consultation alone may not be enough to change what actually happens in a busy clinic. Knowing what to do and having the systems in place to do it consistently are two different things.

The Checklist That Changes Everything

Think of perinatal depression care like a relay race. Each handoff — screening, assessment, treatment, follow-up, referral — needs to happen smoothly or the baton gets dropped. PRISM added a coach to each practice who helped set up the track, train the runners, and make sure the handoffs happened on time.

PRISM (the PRogram In Support of Moms) built on the existing MCPAP training by adding practice-level implementation support — someone working directly with each clinic to make sure the full care pathway was actually followed through, not just understood in theory.

How the Study Was Set Up

Ten obstetric practices in Massachusetts were randomly assigned to receive either MCPAP for Moms alone or MCPAP plus PRISM support. Researchers reviewed medical records for 294 patients who had elevated depression symptoms during the study period. They tracked whether each step of the depression care pathway — screening, treatment, follow-up, and transition planning — actually happened.

What Better Systems Produced

The results showed that practices using PRISM were significantly more likely to complete the full care pathway. Patients in PRISM practices were more than twice as likely to be identified as having perinatal depression. Follow-up monitoring was four times more likely to occur. Care transition plans — which help patients move smoothly from one provider to another — were nearly three times more common.

Screening for bipolar disorder, which often overlaps with perinatal depression and requires different treatment, showed an especially dramatic difference. This step was almost entirely absent in the comparison group and far more common in PRISM practices.

These improvements were not about individual providers caring more — they were about having better systems in place.

The Bigger Picture This Points To

This trial reinforces a key insight in healthcare improvement: clinical outcomes depend not just on what providers know, but on what the practice around them enables. When obstetric offices have structured support to implement care pathways — not just education about them — more women get the help they need. That gap between knowledge and action is where many patients are lost.

What This Means for Patients and Families

If you are pregnant or recently gave birth and are experiencing low mood, anxiety, or feelings of hopelessness, you deserve a thorough screening and a clear follow-up plan from your care team. If that is not happening automatically, it is completely appropriate to ask. Programs like PRISM are helping practices do this better, but access still varies widely by location.

The Honest Limits of This Study

Only 10 practices participated, all in Massachusetts, which limits how broadly the findings apply. The study also focused on process measures — whether steps in the care pathway were completed — rather than directly measuring whether women's depression improved. Larger, more geographically diverse studies are needed.

What Comes Next

If PRISM-style implementation support proves effective across more settings and states, it could inform how perinatal depression programs are designed and funded nationally. Policymakers and health systems are increasingly recognizing that structural support — not just clinical guidelines — is what drives real-world change in maternal mental health care.

Study Details

Study typeRct
EvidenceLevel 2
PublishedApr 2026
View Original Abstract ↓
BACKGROUND: Perinatal depression is common yet undertreated. The Massachusetts Child Psychiatry Access Program (MCPAP) for Moms is a state-wide program to improve access to perinatal depression care by providing training, consultation, and referrals to healthcare professionals serving perinatal women. The PRogram In Support of Moms (PRISM) includes MCPAP for Moms plus practice-level implementation support. This cluster randomized controlled trial compared MCPAP for Moms vs. PRISM in implementation of the perinatal depression care pathway, inclusive of screening, assessment, treatment, follow-up and monitoring, and transition of care. METHODS: Ten obstetric practices were randomized to MCPAP for Moms or PRISM. We abstracted medical record data for perinatal individuals enrolled in the study with elevated depression symptoms (n = 294). Generalized linear mixed-effects models, accounting for clustering of practices, compared post-intervention implementation of the depression care pathway. We also examined changes in implementation via practice leadership surveys. RESULTS: Patients in PRISM practices were more likely to be screened for bipolar disorder (OR = 385.0, p = .001), have treatment engagement documented (OR = 2.8, p = .011), receive follow-up monitoring (OR = 4.0, p = .003), and receive a transition of care plan (OR = 2.7, p = .016). Patients in PRISM practices were more likely to be identified as having perinatal depression (OR = 2.3, p = .001). Practice leadership reported greater increase in capacity to address perinatal depression in PRISM practices (3.7 points, p = .005). CONCLUSIONS: PRISM was associated with greater depression care pathway implementation and improved identification of patients with perinatal depression. In order to help implement new initiatives (i.e. bipolar disorder screening) aligned with the depression care pathway, practice-level assistance may be needed.
Free Newsletter

Clinical research that matters. Delivered to your inbox.

Join thousands of clinicians and researchers. No spam, unsubscribe anytime.